Positron Emission Tomography (PET) News and Research

RSS

Research aimed at increasing shelf life of radiation drugs offers hope for cancer patients

People with hard-to-reach cancers in the kidney, gut and prostate will have improved hope for early diagnosis and treatment with new research aimed at increasing the shelf life of revolutionary radiation drugs.

19 Mar 2020

No evidence of a link between surgery with anesthesia and Alzheimer's disease

Older adults who have surgery with general anesthesia may experience a modest acceleration of cognitive decline, even years later. But there's no evidence of a link to Alzheimer's disease, according to new research from Mayo Clinic.

12 Mar 2020

New imaging agent illuminates cancerous tumors and surrounding cells

Scientists at Washington University School of Medicine in St. Louis have developed a new imaging agent that could let doctors identify not only multiple types of tumors but the surrounding normal cells that the cancer takes over and uses as a shield to protect itself from attempts to destroy it.

10 Mar 2020

NCCN publishes recommendations for assessing quality improvements in cancer care

The National Comprehensive Cancer Network has published a curated list of high-impact measures for assessing quality improvements in cancer care.

10 Mar 2020

PET imaging helps researchers to detect transplant patients with cardiac allograft vasculopathy

Myocardial blood flow and myocardial flow reserve have been identified as accurate indicators for graft failure after cardiac transplantation, according to a new study published in The Journal of Nuclear Medicine.

5 Mar 2020

New radiotracer to improve image-based differential diagnostics of Parkinson’s disease

An interdisciplinary team from the Institute of Radiopharmaceutical Cancer Research headed by Prof. Peter Brust has won HZDR's (Helmholtz-Zentrum Dresden-Rossendorf) third Innovation Contest.

27 Feb 2020

Naturally occurring molecule could improve brain metabolism in patients with MS

N-acetylcysteine is a naturally occurring molecule that replenishes antioxidants and shows improved brain metabolism and self-reported improvements in cognitive function in patients with multiple sclerosis, according to a study published in the journal, Frontiers in Neurology.

26 Feb 2020

Abnormally low levels of a key protein detected in brains of young men with autism

Using cutting-edge imaging technology, researchers at Massachusetts General Hospital (MGH) have shown that the brains of young men with autism spectrum disorder (ASD) have low levels of a protein that appears to play a role in inflammation and metabolism.

23 Feb 2020

MILabs achieves breakthrough in preclinical oncology imaging by eliminating positron range blurring effect

Researchers at MILabs B.V. have succeeded at imaging the popular Zirconium-89 isotope in small animals of human disease at very high resolutions (<0.75 mm).

19 Feb 2020

Inflammation detected in the brains of veterans with Gulf War Illness

In a new discovery, researchers at Massachusetts General Hospital have detected widespread inflammation in the brains of veterans diagnosed with Gulf War Illness.

13 Feb 2020

Researchers receive federal grant to evaluate potential imaging biomarker for Alzheimer's

Researchers at Wake Forest School of Medicine have received a five-year grant worth approximately $2.53 million from the National Institute on Aging to evaluate whether a novel brain-imaging technique can identify Alzheimer's disease in its early stages.

9 Feb 2020

Researchers confirm safety of cancer-specific PET probe in first-in-human clinical studies

A group of researchers led by Assistant Professor WATABE Tadashi of the Graduate School of Medicine of Osaka University achieved the stable domestic production of automatic synthesis modules for positron emission tomography (PET) probe F-18 NKO-035, a LAT1-selective amino acid derivative radiolabeled with 18F, confirming its safety in first-in-human clinical studies conducted at Osaka University Hospital in November 2019.

22 Jan 2020

New antibody-drug conjugate shows promising activity in salivary gland tumors

The antibody-drug conjugate ado-trastuzumab emtansine (T-DM1) has promising activity in HER2 amplified salivary gland tumors, according to data published in the Annals of Oncology.

7 Jan 2020

New clinical study to test retinal screening processes for early detection of Alzheimer's disease

The University of Rhode Island, in collaboration with BayCare Health System in Florida and The Memory and Aging Program at Butler Hospital, an affiliate of The Warren Alpert Medical School of Brown University, is launching a clinical trial of retinal screening processes that could help clinicians detect Alzheimer's disease possibly two or more decades before patients develop life-altering clinical symptoms.

6 Jan 2020

New radiotracer can provide insights into how the heart recovers after myocardial infarction

Insights into how the heart recovers after myocardial infarction (heart attack) can be obtained with a new radiotracer that targets fibroblast activity prior to it causing permanent damage.

2 Jan 2020

Risk of specific genetic translocation is higher in patients of African ancestry, shows study

Multiple myeloma is a plasma cell cancer that is more common in patients of African American descent than of European American descent.

10 Dec 2019

Chronic psychosocial adversity impairs dopamine production

People exposed to a lifetime of psychosocial adversity may have an impaired ability to produce the dopamine levels needed for coping with acutely stressful situations.

12 Nov 2019

Serum flotillin level can serve as blood marker for early diagnosis of Alzheimer's disease

Currently, best-characterized indicators for Alzheimer's disease diagnosis are the decreased levels of amyloid β-protein 42 and increased levels of phosphorylated tau in cerebrospinal fluid.

4 Nov 2019

Education level and socioeconomic status can predict thinking and memory performance

How well eight-year-olds score on a test of thinking skills may be a predictor of how they will perform on tests of thinking and memory skills when they are 70 years old, according to a study published in the October 30, 2019, online issue of Neurology, the medical journal of the American Academy of Neurology.

31 Oct 2019

New biomarker can track mitochondrial activity in lung tumors

Researchers at the UCLA Jonsson Comprehensive Cancer Center and David Geffen School of Medicine at UCLA have identified a new biomarker using a noninvasive imaging method that tracks mitochondrial activity in lung tumors.

30 Oct 2019